Eli Lilly and German Startup Collaborating on Cancer Immunotherapies
Pharma giant Eli Lilly and Company and a German startup have reached a highly-incentivized agreement to collaborate on new cancer treatments arming the body’s immune system to fight tumors, the companies announced.
Source: www.dddmag.com